ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag policy evolution funding cancer

Speaking of Science
The Scientist | Jan 1, 2012 | 2 min read
January 2012's selection of notable quotes
Week in Review: February 6–10
Tracy Vence | Feb 9, 2017 | 3 min read
Two potential Science Advisors to the President talk federal funding, climate change research, science marches, and more; a conversation with Iranian-American geneticist Pardis Sabeti; standards for teaching evolution in Texas could change; bioengineers debut a stomach acid–powered ingestible sensor; toward killing cancer with bacteria; ecDNA and tumor evolution
Science and Politics in 2012
Bob Grant | Dec 19, 2012 | 4 min read
This year, US politics was dominated by the run-up to October elections, with science policy issues playing a role here and elsewhere around the world.
Opinion: Ethical Boundaries Needed on the Uses of Synthetic DNA
John D. Loike and Robert Pollack | Mar 1, 2019 | 4 min read
A newly expanded genetic alphabet that includes four synthetic nucleotides highlights the need for strict boundaries on their use.
How Orphan Drugs Became a Highly Profitable Industry
Diana Kwon | May 1, 2018 | 10+ min read
Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.
2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
A photo of King Charles III, then formally Prince of Wales, wearing a dark suit, shown from the shoulders up.
The Unscientific King: Charles III’s History Promoting Homeopathy
Sophie Fessl, PhD | Sep 29, 2022 | 6 min read
King Charles III has a long history of promoting homeopathic or alternative medical treatments not supported by scientific evidence.
Book Excerpt from The Politics of Cancer
Wendy N. Whitman Cobb | Mar 31, 2017 | 4 min read
In Chapter 2, “Identifying the Culprits,” author Wendy Whitman Cobb describes how small-government, anti-regulation conservatism can hinder the fight against cancer.
Genome Project Ethics Office Is Achieving New Prominence In National Policy Debates
Franklin Hoke | Oct 2, 1994 | 8 min read
Sidebar:Active and Recently Completed NIH ELSI Research Projects With passage of time and increasing political relevance, HGP branch's influence is on the rise among decision-makers Beginning this year, the component of the United States human genome initiative that has been sponsoring studies of the ethical, legal, and social implications of the massive genome effort's ground-breaking research will be reporting the first hard resul
Genome Project Ethics Office Is Achieving New Prominence In National Policy Debates
Franklin Hoke | Oct 2, 1994 | 8 min read
Sidebar:Active and Recently Completed NIH ELSI Research Projects With passage of time and increasing political relevance, HGP branch's influence is on the rise among decision-makers Beginning this year, the component of the United States human genome initiative that has been sponsoring studies of the ethical, legal, and social implications of the massive genome effort's ground-breaking research will be reporting the first hard resul

Run a Search

ADVERTISEMENT